Funded Biotechnology Startups in Berlin
Berlin's biotechnology funding activity across these 22 rounds spans August 2020 through June 2025, with Seed and Series Unknown rounds accounting for the…
Berlin's biotechnology funding activity across these 22 rounds spans August 2020 through June 2025, with Seed and Series Unknown rounds accounting for the largest share of transactions. The standout raise is T-knife's $110M Series B in August 2021; Formo ($36M, January 2025) and Noxxon Pharma ($19M Post-IPO Debt, January 2022) are the next largest disclosed amounts. 2024 was the most active year in this dataset, with nine rounds between February and October — from Pacifico Biolabs' $3M Pre-Seed to Booster Therapeutics' $15M Seed.
Sub-sector coverage is wide. Names like Lucid Genomics, MyoPax, Tacalyx, and T-knife suggest genomics, muscle-related therapeutics, and oncology threads, while Cultimate Foods and MushLabs suggest food and fungi biotech applications. Two rounds — Viride and infinit Bio — closed at undisclosed amounts, and Noxxon Pharma is the only company in this set to carry a Post-IPO financing.
Most recent rounds
22 shownRelated listings
Frequently asked
What are the largest recent rounds among Berlin biotechnology companies?
T-knife raised $110M in a Series B in August 2021, the largest disclosed amount in this set. Formo follows with $36M in January 2025 and Noxxon Pharma with $19M via Post-IPO Debt in January 2022. Booster Therapeutics' $15M Seed in October 2024 stands out as the largest seed-stage raise shown.
Which funding stages appear most often across these Berlin biotech rounds?
Seed is the most common stage, with seven companies — including Nuuron, Booster Therapeutics, Tacalyx, Cultimate Foods, and Nia Health — raising at that level. Four rounds carry a Series Unknown classification, and Pre-Seed appears three times across Lucid Genomics, Pacifico Biolabs, and infinit Bio.
How active was Berlin biotech deal flow in 2024 specifically?
Nine of the 22 rounds closed in 2024, making it the most represented calendar year in this dataset. Disclosed amounts ranged from Lucid Genomics' $1M Pre-Seed in September to Booster Therapeutics' $15M Seed in October, with Sanity Group ($12M), Tacalyx ($8M), and Cultimate Foods ($3M) also closing mid-year.
Which Berlin biotech companies have reached Series A or later?
T-knife (Series B, $110M, August 2021) and Labforward (Series B, $6M, January 2021) represent the two Series B raises in this set. inne ($10M Series A, May 2022) and Dopavision ($14M Series A, July 2021) completed Series A rounds. Noxxon Pharma, the only post-public company shown, raised $19M in Post-IPO Debt in January 2022.
What is the most recently funded Berlin biotech company in this listing?
Pheiron closed the most recent round, raising $4M in a Series Unknown transaction dated June 20, 2025. Before that, Formo raised $36M on January 14, 2025 — the largest disclosed amount in 2025 within this dataset.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.